Sunshine Nuohuo: Plans to invest 20 million yuan with own funds to participate in Ruyang Biological's layout of innovative drugs

2026-03-10 05:23:28

Abstract generation in progress

Recently, Sunshine Nuohuo announced that it plans to invest 20 million yuan of its own funds to subscribe to an additional registered capital of 570,000 yuan for Ruiyang (Shandong) Biopharmaceutical Co., Ltd. After the capital increase, it will hold a 1.6721% stake in the company.

The announcement states that Ruiyang Biotech was established in 2024 with a registered capital of 31 million yuan. It mainly engages in the research, development, and industrialization of antibody-based biological macromolecular drugs. This investment will help the company strengthen its technological reserves and industrial chain layout in innovative drug R&D, enhancing its overall competitiveness.

(Sunshine Nuohuo Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.